Synmosa Biopharma Corporation (4114.TWO)

TWD 31.25

(0.32%)

EBITDA Summary of Synmosa Biopharma Corporation

  • Synmosa Biopharma Corporation's latest annual EBITDA in 2023 was 1 Billion TWD , down -8.4% from previous year.
  • Synmosa Biopharma Corporation's latest quarterly EBITDA in 2024 Q2 was 293.41 Million TWD , up 3.68% from previous quarter.
  • Synmosa Biopharma Corporation reported an annual EBITDA of 1.1 Billion TWD in 2022, up 117.44% from previous year.
  • Synmosa Biopharma Corporation reported an annual EBITDA of 524.31 Million TWD in 2021, down -24.86% from previous year.
  • Synmosa Biopharma Corporation reported a quarterly EBITDA of 286.01 Million TWD for 2024 Q1, up 10.67% from previous quarter.
  • Synmosa Biopharma Corporation reported a quarterly EBITDA of 263.47 Million TWD for 2023 Q4, up 13.52% from previous quarter.

Annual EBITDA Chart of Synmosa Biopharma Corporation (2023 - 2019)

Historical Annual EBITDA of Synmosa Biopharma Corporation (2023 - 2019)

Year EBITDA EBITDA Growth
2023 1 Billion TWD -8.4%
2022 1.1 Billion TWD 117.44%
2021 524.31 Million TWD -24.86%
2020 678.35 Million TWD 269.09%
2019 183.79 Million TWD 0.0%

Peer EBITDA Comparison of Synmosa Biopharma Corporation

Name EBITDA EBITDA Difference
Allied Biotech Corporation 204.79 Million TWD -392.568%
GeneFerm Biotechnology Co., Ltd. 231.09 Million TWD -336.506%
Easywell Biomedicals, Inc. -85.5 Million TWD 1279.798%
TTY Biopharm Company Limited 1.52 Billion TWD 33.827%
Orient EuroPharma Co., Ltd. 582.93 Million TWD -73.044%
Center Laboratories, Inc. -175.17 Million TWD 675.863%
Tien Liang BioTech Co., Ltd. 31.04 Million TWD -3148.966%
Orient Pharma Co., Ltd. 172.39 Million TWD -485.132%
InnoPharmax Inc. -62.12 Million TWD 1723.855%
Johnson Chemical Pharmaceutical Works Co., Ltd. 126.67 Million TWD -696.302%
Excelsior Biopharma Inc. -29.36 Million TWD 3534.707%
DV Biomed Co., Ltd. 407.64 Million TWD -147.458%
Foresee Pharmaceuticals Co., Ltd. -912.16 Million TWD 210.588%
Handa Pharmaceuticals, Inc. 802.78 Million TWD -25.655%
UniPharma Co., Ltd. -16.25 Million TWD 6306.097%
Anxo Pharmaceutical Co., Ltd. 131.31 Million TWD -668.212%
Alar Pharmaceuticals Inc. 394.52 Million TWD -155.688%
Winston Medical Supply Co., Ltd. 228.32 Million TWD -341.8%
Mercury Biopharmaceutical Corporation -39.03 Million TWD 2684.257%
Bioray Biotech Co., Ltd 12.13 Million TWD -8212.641%
TSH Biopharm Corporation Limited 99.35 Million TWD -915.339%